Genetic influences on cognitive endophenotypes in schizophrenia

Abstract

Background Cognitive deficits are prominent in schizophrenia and represent promising endophenotypes for genetic research. Methods The current study investigated the importance of two conceptually distinct genetic aggregates, one based on copy number variations (uncommon deletion burden), and one based on single nucleotide polymorphisms identified in recent risk studies (genetic risk score). The impact of these genetic factors, and their interaction, was examined on cognitive endophenotypes defined by principal component analysis (PCA) in a multi-center sample of 50 patients with schizophrenia and 86 controls. PCA was used to identify three different types of executive function (EF: planning, fluency, and inhibition), and in separate analyses, a measure general cognitive ability (GCA). Results Cognitive deficits were prominent among individuals with schizophrenia, but no group differences were evident for either genetic factor. Among patients the deletion burden measures predicted cognitive deficits across the three EF components and GCA. Further, an interaction was noted between the two genetic factors for both EF and GCA and the observed patterns of interaction suggested antagonistic epistasis. In general, the set of genetic interactions examined predicted a substantial portion of variance in these cognitive endophenotypes. Limitations Though adequately powered, our sample size is small for a genetic study. Conclusions These results draw attention to genetic interactions and the possibility that genetic influences on cognition differ in patients and controls.

Analysis of Association of Genetic Markers in the LUZP2 and FBXO40 Genes with the Normal Variability in Cognitive Performance in the Elderly

“…Cognitive decline with the age, both in the normal aging and in the pathological manifestations in form of dementia, is an important public health and social challenge. Individual variability of cognitive functions is an important endophenotype of many neurodegenerative, psychiatric, and mental diseases, such as schizophrenia (SZ) [ 1 ], Alzheimer's diseases (AD) [ 2 ], bipolar disorder [ 3 ], and attention-deficit hyperactivity disorder [ 4 ]. Recent genome-wide association studies (GWAS) have revealed dozens of single nucleotide polymorphisms (SNPs) associated with a cognitive performance in SZ or AD patients, as well as in normal healthy subjects [ 5 – 10 ].…”

CACNA1C rs1006737 genotype and bipolar disorder: Focus on intermediate phenotypes and cardiovascular comorbidity

“…One approach that has recently generated progress regarding our understanding of the pathophysiology of psychiatric disorders is that of intermediate phenotypes (also described as endophenotypes) (Erk et al, 2013;Insel and Cuthbert, 2009;Yeo et al, 2014). Advances in functional and structural brain MRI have provided alternative methods for studying core phenotypes that may be more proximal to genetic contributions and that may underlie psychiatric illness (Hariri et al, 2006).…”

Polygenic signal for symptom dimensions and cognitive performance in patients with chronic schizophrenia

“…In the Philadelphia neurodevelopmental cohort, investigators also found schizophrenia PRS associations for speed of emotion identification, an aspect of social cognition ( Germine et al, 2016 ). Earlier studies utilizing genetic risk scores did not find associations with cognitive domains ( Yeo et al, 2014 ) or IQ in schizophrenia ( Van Scheltinga et al, 2013 ), though the lack of association could be explained by smaller sample sizes.…”